Robert WestRobert West is a tenure-track assistant professor of computer science at EPFL, where he heads the Data Science Lab. In his research, he develops and applies techniques in machine learning, computational social science, natural language processing, social network analysis, and data mining. Bob also collaborates closely with the Wikimedia Foundation, in his role as a Wikimedia Research Fellow. Bob’s work has won several awards, including best/outstanding paper awards at ICWSM’21, ICWSM’19, and WWW’13, a best-paper runner-up award at WWW’16, a Google Faculty Research Award, a Facebook Research Award, a Hewlett-Packard Graduate Fellowship, and a Facebook Graduate Fellowship. He is actively involved in the research community, e.g., as an Associate Editor of ICWSM and EPJ Data Science and as a co-founder of the Wiki Workshop (held at WWW and ICWSM) and the Applied Machine Learning Days. Bob received his PhD in Computer Science from Stanford University, his MSc from McGill University, Canada, and his undergraduate degree from Technische Universität München, Germany.[Last updated: 25 Aug 2021]
Johan AuwerxJohan Auwerx is Professor at the École Polytechnique Fédérale in Lausanne, Switzerland, where he occupies the Nestle Chair in Energy Metabolism. Dr. Auwerx has been using molecular physiology and systems genetics to understand metabolism in health, aging and disease. Much of his work focused on understanding how diet, exercise and hormones control metabolism through changing the expression of genes by altering the activity of transcription factors and their associated cofactors. His work was instrumental for the development of agonists of nuclear receptors - a particular class of transcription factors - into drugs, which now are used to treat high blood lipid levels, fatty liver, and type 2 diabetes. Dr. Auwerx was amongst the first to recognize that transcriptional cofactors, which fine-tune the activity of transcription factors, act as energy sensors/effectors that influence metabolic homeostasis. His research validated these cofactors as novel targets to treat metabolic diseases, and spurred the clinical use of natural compounds, such as resveratrol, as modulators of these cofactor pathways.
Johan Auwerx was elected as a member of EMBO in 2003 and is the recipient of a dozen of international scientific prizes, including the Danone International Nutrition Award, the Oskar Minkowski Prize, and the Morgagni Gold Medal. His work is highly cited by his peers with a h-factor of over 100. He is an editorial board member of several journals, including Cell Metabolism, Molecular Systems Biology, The EMBO Journal, Journal of Cell Biology, Cell, and Science. Dr. Auwerx co-founded a handful of biotech companies, including Carex, PhytoDia, and most recently Mitobridge, and has served on several scientific advisory boards.
Dr. Auwerx received both his MD and PhD in Molecular Endocrinology at the Katholieke Universiteit in Leuven, Belgium. He was a post-doctoral research fellow in the Departments of Medicine and Genetics of the University of Washington in Seattle.
Hilal Lashuel2012-2013 Visiting Professor, Standford University. Stanford School of Medicine
2011- Associate Professor of Life Sciences-Brain Mind Institute-EPFL
Dir. Laboratory of Chemical Biology of Neurodegeneration
2005-2011 Assistant Professor of Life Sciences-Brain Mind Institute-EPFL
Dir. Laboratory of Molecular Neurobiology and Neuroproteomics
2005-2008 Director- EPFL Proteomic Core Facility
2002-2004 Instructor of Neurology- Harvard Medical School and Brigham and Women's
Hospital
2001-2002 Sabbatical Fellow- Laboratory for Drug Discovery in Neurodegeneration
Harvard Medical School,
2001-2002 Post-doctoral Fellow- Center for Neurologic Diseases
Harvard Medical School and Brigham and Women's Hospital
Advisor- Prof. Peter T. Lansbury
2000-2001 Research Scientist, The Picower Institute for Medical Research, Great Neck
New York
1994-2000 PhD Student; Texas A&M University and the Scripps Research Institute
Advisor- Prof. Jeffery W. Kelly
1990-1994 B.S. City University of New York, Brooklyn College
Dr. Hilal A. Lashuel received his B.Sc. degree in chemistry from the City University of New York in 1994 and completed his doctoral studies at Texas A&M University and the Scripps Research Institute in 2000. After obtaining his doctoral degree, he became a research fellow at the Picower Institute for Medical Research in Long Island New York. In 2001, he moved to Harvard Medical School and the Brigham and Women's Hospital as a research fellow in the Center for Neurologic Diseases and was later promoted to an instructor in neurology at Harvard Medical School. During his tenure (2001-2004) at Harvard Medical School his work focused on understanding the mechanisms of protein misfolding and fibrillogenesis and the role of these processes in the pathogenesis of Parkinson's and Alzheimer's disease. In 2005 Dr. Lashuel moved Switzerland to join the Brain Mind Institute at the Swiss Federal Institute of Technology Lausanne as a tenure-track assistant professor in neurosciences. Currently, Dr. Lashuel is an associate professor of life sciences and the director of the laboratory of molecular and chemical biology of neurodegeneration. (http://lashuel-lab.epfl.ch/).
Research efforts in the Lashuels laboratory focus on understanding the molecular mechanisms of neurodegeneration and developing novel strategies to diagnose and treat neurodegenerative diseases such as Alzheimers and Parkinsons disease. Research in the Lashuel lab is funded by several international funding agencies and foundations, including the Swiss National Science Foundation, European FP7 program (Marie Curie and ERC grants), Human Science Frontiers, Strauss Foundation, Cure the Huntingtons disease foundation and Michael J Fox foundation and is supported by collaborations with pharmaceutical and biotech companies (http://lashuel-lab.epfl.ch/page-50538-en.html), Nestle, Merck-Serono, AC Immune and Johnson and Johnson.
Dr. Lashuels research has resulted in the characterization of novel quaternary structure intermediates on the amyloid pathway, identification of potential therapeutic targets, and new hypotheses concerning the mechanisms of pathogenesis in Alzheimers disease, Parkinsons disease and related disorders. Dr. Lashuel scientific contribution to this field includes i) more than100 publications in major peer reviewed journals including Nature journals, Cell, PNAS, JBC, J. Neuroscience JACS, and Angewandtie Chemie; ii) three patents on novel strategies for preventing protein aggregation and treating autoimmune and inflammatory diseases; iii) more than 150 invited lectures since 2002 and more than 5500 citations (7800 citation-Google Scholar) since 1996. Dr. Lashuel has received several pre-doctoral and post-doctoral awards and fellowships and was the recipient of two prestigious awards given to young investigators; Human Science Frontiers young investigator research award and the European Research Council (ERC) starting independent researcher grant and the ERC proof of concept award (2013) These awards provide more than $2.5 Million to Dr. Lashuel to translate some of his ideas and projects into novel strategies for diagnosing and treating neurodegenerative diseases such as Alzheimers and Parkinsons disease. Dr. Lashuel has chaired and co-organized several international conferences and serves as an academic editor for PLoS ONE, an associate editor for frontiers of molecular neuroscience, member of the Editorial advisory board of ChemBioChem and ad hoc reviewer for several international scientific journals and funding agencies. Dusan LicinaDusan Licina is a Tenure Track Assistant Professor of Indoor Environmental Quality at the School for Architecture, Civil, and Environmental Engineering (ENAC) at EPFL. He leads the Human-Oriented Built Environment Lab (HOBEL) in Fribourg since 1 June 2018. Dusan’s research and teaching are driven by the need to advance knowledge of the intersections between people and the built environment in order to ensure high indoor environmental quality for building occupants with minimum energy input. His research group specializes in air quality engineering, focusing on understanding of concentrations, dynamics and fates of air pollutants within buildings, and development and application of methods to quantitatively describe relationships between air pollution sources and consequent human exposures. His research interests also encompass optimization of building ventilation systems with an aim to improve air quality and thermal comfort in an energy-efficient manner. Throughout his career, Dusan specialized in air quality engineering, focusing on sources and transport of air pollutants in buildings, human exposure assessment, and optimization of building ventilation systems with an aim to improve air quality. Dusan completed my joint Doctorate degree at the National University of Singapore and Technical University of Denmark. He was formerly master and bachelor student in Mechanical Engineering at the University of Belgrade, Serbia. Prior to joining EPFL, Dusan worked for 3.5 years in the USA, first he was a postdoctoral researcher at the University of California Berkeley, and then he served as director on the standard development team at International WELL Building Institute (IWBI) in New York. Dusan is the recipient of several honors and awards, including Ralph G. Nevin’s award by the American Society of Heating, Refrigerating and Air-Conditioning Engineers (ASHRAE) given in recognition of significant accomplishment in the study of human response to the environment. He is editorial board member of the highly acclaimed Indoor Air journal. He is passionate about raising awareness about the air quality issues worldwide and developing buildings that are not only energy efficient, but that also contribute to “Michelin Star” indoor air quality.
Vitor Pessoa ColomboVitor grew up in São Paulo (Brazil) and studied architecture in Switzerland (B.Sc. École Polytechnique Fédérale de Lausanne, M.Sc. Accademia di Architettura di Mendrisio). Since 2016, he has conducted research on urbanization processes in cities of the global South. He has focused his research on "citizen mapping" methods that provide spatial information useful to support the improvement of vulnerable human settlements in cities marked by socio-spatial segregation. Now he conducts a PhD project at EPFL's CEAT unit to investigate how different urban morphologies relate to the occurence of diarrhoeal diseases in the context of rapid and largely informal urbanization processes.
